Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery LesionsJong‐Young Lee, Seung‐Jung Park, Nae‐Hee Lee et al.|Circulation Cardiovascular Interventions|2014Cited by 34
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Young Bin Song, Joo‐Yong Hahn et al.|Cardiology Journal|2021Cited by 23
Impact of Hospital Volume of Percutaneous Coronary Intervention (PCI) on In-Hospital Outcomes in Patients with Acute Myocardial Infarction: Based on the 2014 Cohort of the Korean Percutaneous Coronary Intervention (K-PCI) RegistryByong-Kyu Kim, Min Su Hyon, Deuk-Young Nah et al.|Korean Circulation Journal|2020Cited by 8
Three-Year Clinical Outcomes of a Thin-Strut Biodegradable-Polymer Everolimus-Eluting Stent in Patients With Acute Coronary SyndromeDoo Sun Sim, Jang‐Ho Bae, Dae Young Hyun et al.|Journal of Cardiovascular Intervention|2022Cited by 3
Three-Year Outcomes of a Bioabsorbable-Polymer Sirolimus-Eluting Stent in Patients With Acute Coronary Syndrome in KoreaSeok Oh, Myung Ho Jeong, Min Chul Kim et al.|Journal of Cardiovascular Intervention|2025Cited by 1